In this episode of Neurocareers Doing the Impossible, Milena Korostenskaja interviews Dr. Amanda Wiggins, CEO of the cGP Lab, about her atypical career path in neuroscience. Dr. Wiggins shares her journey from shaping New Zealand's human tissue bill to leading regulatory frameworks for stem cell therapies and cell transplantation. She discusses her academic background, her transition into regulatory work and the biotech industry, and her current role at cGP Lab, where she is involved in groundbreaking work in cycling glycine proline for neurological health. She provides insights into the challenges and rewards of working at the intersection of science, business, and regulation, and offers advice for those interested in pursuing a similar path.
Sign in to continue reading, translating and more.
Continue